Brian Singerman
Brian Singerman is an American venture capitalist and businessman. He is a partner emeritus at Founders Fund, a San Francisco-based venture capital firm with over $11 billion under management.
Early life and education
Singerman graduated from Stanford University in 1999 with a B.S. in Computer Science. Following Stanford, he joined the virtual-world online start-up There as a software engineer.Career
During his tenure at Google, Singerman began his investment career, launching a $1 million fund called XGYC Fund, short for "ex-Google, Y Combinator."
Founders Fund
In 2008, Singerman joined Founders Fund, where he works alongside Peter Thiel and Ken Howery. He focuses on healthcare, biotechnology, wearable computing, and robotics.Singerman has been a board director for several companies, including Affirm, Cloud9, Emerald Therapeutics, The Long-Term Stock Exchange, Oscar Health, and Postmates. Additionally, he has served as a board observer for Airbnb, Forward, and Wish.
On December 3, 2024, Singerman announced his transition to the role of partner emeritus at Founders Fund, planning to continue as a strategic advisor while prioritizing a new work-life balance.
Notable investments
One of Singerman's most prominent investments was in Stemcentrx, a biotechnology firm focused on cancer therapies. In April 2016, AbbVie acquired Stemcentrx in a transaction valued at up to $10.2 billion, marking the largest portfolio exit in Founders Fund's history. However, in 2019, AbbVie shuttered Stemcentrx after its lead cancer drug, Rova-T, failed to outperform placebo in a Phase 3 clinical trial.He has also been involved in investments in Oculus VR and Postmates.